SAFETY AND EFFICACY OF DUAL THERAPY WITH DABRAFENIB AND TRAMETINIB IN AN INFANT WITH BRAF V600E MUTANT INOPERABLE LOW GRADE GLIOMA

被引：0
|
作者：
Green, Sage [1 ]
Walter, Andrew [1 ]
Piatt, Joseph [1 ]
Kaur, Gurcharanjeet [1 ]
机构：
[1] Nemours AI duPont Hosp Children, Wilmington, DE USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
10.1093/neuonc/noab090.136
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LGG-12
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600-Mutant Low-Grade Glioma
    Bouffet, Eric
    Geoerger, Birgit
    Moertel, Christopher
    Whitlock, James A.
    Aerts, Isabelle
    Hargrave, Darren
    Osterloh, Lisa
    Tan, Eugene
    Choi, Jeea
    Russo, Mark
    Fox, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 664 - +
  • [2] Dabrafenib plus trametinib combination therapy in pediatric patients with BRAF V600-mutant low-grade glioma: Safety and efficacy results.
    Geoerger, Birgit
    Bouffet, Eric
    Whitlock, James A.
    Moertel, Christopher L.
    Hargrave, Darren R.
    Aerts, Isabelle
    Cohen, Kenneth J.
    Kilburn, Lindsay Baker
    Wright, Karen D.
    Choi, Jeea
    Gasal, Eduard
    Russo, Mark W.
    Fox, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Dabrafenib plus trametinib in BRAF V600E-mutant high-grade (HGG) and low-grade glioma (LGG).
    Subbiah, Vivek
    Stein, Alexander
    van den Bent, Martin
    Wick, Antje
    de Vos, Filip Y.
    von Bubnoff, Nikolas
    van Linde, Myra E.
    Lai, Albert
    Prager, Gerald W.
    Campone, Mario
    Fasolo, Angelica
    Lopez-Martin, Jose A.
    Kim, Tae Min
    Hofheinz, Ralf-Dieter
    Blay, Jean-Yves
    Cho, Daniel C.
    Gazzah, Anas
    Pouessel, Damien
    Yachnin, Jeffrey
    Boran, Aislyn
    Burgess, Paul
    Ilankumaran, Palanichamy
    Gasal, Eduard
    Wen, Patrick Y.
    CANCER RESEARCH, 2021, 81 (13)
  • [4] EFFICACY AND SAFETY OF DABRAFENIB plus TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E-MUTATED LOW-GRADE GLIOMA (LGG)
    Wen, Patrick
    De Greve, Jacques
    Mason, Warren
    Hofheinz, Ralf-Dieter
    Dietrich, Sascha
    de Vos, Filip
    van den Bent, Martin
    Mookerjee, Bijoyesh
    Boran, Aislyn
    Burgess, Paul
    Rangwala, Fatima
    Gazzah, Anas
    NEURO-ONCOLOGY, 2018, 20 : 238 - 238
  • [5] SAFETY AND EFFICACY OF TRAMETINIB (T) MONOTHERAPY AND DABRAFENIB plus TRAMETINIB (D plus T) COMBINATION THERAPY IN PEDIATRIC PATIENTS WITH BRAF V600-MUTANT LOW-GRADE GLIOMA (LGG)
    Bouffet, Eric
    Whitlock, James A.
    Moertel, Christopher
    Geoerger, Birgit
    Aerts, Isabelle
    Hargrave, Darren
    Cohen, Kenneth J.
    Kilburn, Lindsay B.
    Upadhyaya, Santhosh A.
    Wetmore, Cynthia
    Wright, Karen D.
    Choi, Jeea
    Gasal, Eduard
    Russo, Mark W.
    Fox, Elizabeth
    NEURO-ONCOLOGY, 2020, 22 : 375 - 375
  • [6] Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib
    Jansen, Yanina J.
    Janssens, Peter
    Hoorens, Anne
    Schreuer, Max S.
    Seremet, Teofila
    Wilgenhof, Sofie
    Neyns, Bart
    MELANOMA RESEARCH, 2015, 25 (06) : 550 - 554
  • [7] EFFICACY AND SAFETY OF DABRAFENIB plus TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E-MUTATED HIGH-GRADE GLIOMA (HGG)
    Wen, Patrick
    Alexander, Stein
    Yung-Jue, Bang
    van den Bent, Martin
    Gazzah, Anas
    Dietrich, Sascha
    de Vos, Filip
    van Linde, Mayra
    Lai, Albert
    Chi, Andrew
    Prager, Gerald
    Campone, Mario
    von Bubnoff, Nikolas
    Fasolo, Angelica
    Lopez-Martin, Jose
    Mookerjee, Bijoyesh
    Boran, Aislyn
    Burgess, Paul
    Rangwala, Fatima
    Subbiah, Vivek
    NEURO-ONCOLOGY, 2018, 20 : 238 - 238
  • [8] UPDATED EFFICACY AND SAFETY OF DABRAFENIB PLUS TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E-MUTATED HIGH-GRADE GLIOMA (HGG) AND LOW-GRADE GLIOMA (LGG)
    Wen, Patrick
    Stein, Alexander
    van den Bent, Martin
    De Greve, Jacques
    Dietrich, Sascha
    De Vos, Filip
    von Bubnoff, Nikolas
    van Linde, Myra
    Lai, Albert
    Prager, Gerald
    Campone, Mario
    Fasolo, Angelica
    Lopez-Martin, Jose
    Kim, Tae Min
    Mason, Warren
    Hofheinz, Ralf-Dieter
    Blay, Jean-Yves
    Cho, Daniel
    Gazzah, Anas
    Gomez-Roca, Carlos
    Yachnin, Jeffrey
    Boran, Aislyn
    Burgess, Paul
    Palanichamy, Ilan
    Gasal, Eduard
    Subbiah, Vivek
    NEURO-ONCOLOGY, 2019, 21 : 19 - 19
  • [9] BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Del Bufalo, Francesca
    Ceglie, Giulia
    Cacchione, Antonella
    Alessi, Iside
    Colafati, Giovanna Stefania
    Carai, Andrea
    Diomedi-Camassei, Francesca
    De Billy, Emmanuel
    Agolini, Emanuele
    Mastronuzzi, Angela
    Locatelli, Franco
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [10] Trametinib plus dabrafenib for unresectable or metastatic melanoma with BRAF V600E or V600K mutations
    Abraham, Jame
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (07): : 234 - 235
12345